HIGHLIGHTS
- who: Yujing Cheng from the Capital Medical University, China have published the paper: Influence of CYP2C19 genetic variants and smoking on dual antiplatelet efficacy in patients with coronary artery disease, in the Journal: (JOURNAL) of 24/01/2023
- what: This study was approved by the Institutional Review Board (approval no. 2019028), and informed consent was obtained from all participants.
- future: In future further studies and clinical experience should be considered for individualized DAPT. Investigations are required to identify the underlying mechanism and to verify the results .
SUMMARY
This study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.